亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

安徽德信佳生物醫藥有限公司  

醫藥原料及醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:付春枚
  • 電話:0531-82375809
  • 郵件:maple@jndxj.com
  • 傳真:0531-82375893
  • QQ:1106056172
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 2-哌甲酸 535-75-1
2-哌甲酸 535-75-1
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
過期 長期有效
更新 2015-08-19 11:08
 
詳細信息

中間體Piperidine-2-carboxylic acid  2-啶甲酸 535-75-1   4043-87-2    ≥98%    2-六氫吡啶羧酸
中間體Piperidine-3-carboxylic acid 3-啶甲酸    498-95-3 ≥97%
中間體 Piperidine-4-carboxylic acid 4-哌甲酸   498-94-2   ≥99%
(S)-(+)-Nipecotic acid  (S)-3-哌甲酸   59045-82-8     ≥98%
N-BOC- Piperidine-2-carboxylic acid N -Boc-2-哌甲酸  CAS: 98303-20-9
N-BOC- Piperidine-3-carboxylic acid N-BOC-3-哌甲酸    84358-12-3
©2025 安徽德信佳生物醫藥有限公司 版權所有   技術支持:化工網   訪問量:7272  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |